Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if imaging with [18F]FDG and [18F]DPA-714 using positron
emission tomography and computed tomography (PET/CT) will show lung inflammation and fibrosis
in patients diagnosed with idiopathic pulmonary fibrosis (IPF). This study may help
physicians and researchers better understand how best to treat patients with IPF in the
future.